Wenfeng Zeng

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Toll Like Receptor

Radiation Therapy

Inflammatory Response

Top Venues

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Liyan Lao, Wenfeng Zeng, Penghan Huang, Huiping Chen, Zishuo Jia, Pei Wang, Di Huang, Jianing Chen, Yan Nie, Linbin Yang, Wei Wu, Jiang Liu
CD8+ T cell-dependent remodeling of the tumor microenvironment overcomes chemoresistance. Cancer immunology research (2023)
Liyan Lao, Wenfeng Zeng, Penghan Huang, Huiping Chen, Zishuo Jia, Pei Wang, Di Huang, Jianing Chen, Yan Nie, Linbin Yang, Wei Wu, Jiang Liu
CD8+ T cell-Dependent Remodeling of the Tumor Microenvironment Overcomes Chemoresistance. Cancer immunology research 11 (3) (2023)
Liyan Lao, Wenfeng Zeng, Penghan Huang, Huiping Chen, Zishuo Jia, Pei Wang, Di Huang, Jianing Chen, Yan Nie, Linbin Yang, Wei Wu, Jiang Liu
CD8+ T cell-Dependent Remodeling of the Tumor Microenvironment Overcomes Chemoresistance. Cancer immunology research 11 (3) (2023)
Liyan Lao, Wenfeng Zeng, Penghan Huang, Huiping Chen, Zishuo Jia, Pei Wang, Di Huang, Jianing Chen, Yan Nie, Linbin Yang, Wei Wu, Jiang Liu
CD8+ T cell-Dependent Remodeling of the Tumor Microenvironment Overcomes Chemoresistance. Cancer immunology research 11 (3) (2023)
Wenfeng Zeng, Lixiong Xiong, Wei Wu, Shunrong Li, Jiang Liu, Linbing Yang, Liyan Lao, Penghan Huang, Mengmeng Zhang, Huiping Chen, Nanyan Miao, Zhirong Lin, Zifei Liu, Xinyu Yang, Jiayi Wang, Pei Wang, Erwei Song, Yandan Yao, Yan Nie, Jianing Chen, Di Huang
CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype. Oncogene (2022)